200 related articles for article (PubMed ID: 9684851)
1. The lipoprotein and coronary atherosclerosis study (LCAS): lipid and metabolic factors related to atheroma and clinical events.
Herd JA
Am J Med; 1998 Jun; 104(6A):42S-49S. PubMed ID: 9684851
[TBL] [Abstract][Full Text] [Related]
2. Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS]).
Herd JA; Ballantyne CM; Farmer JA; Ferguson JJ; Jones PH; West MS; Gould KL; Gotto AM
Am J Cardiol; 1997 Aug; 80(3):278-86. PubMed ID: 9264419
[TBL] [Abstract][Full Text] [Related]
3. The Lipoprotein and Coronary Atherosclerosis Study (LCAS): design, methods, and baseline data of a trial of fluvastatin in patients without severe hypercholesterolemia.
West MS; Herd JA; Ballantyne CM; Pownall HJ; Simpson S; Gould L; Gotto AM
Control Clin Trials; 1996 Dec; 17(6):550-83. PubMed ID: 8974213
[TBL] [Abstract][Full Text] [Related]
4. Baseline characteristics of subjects in the Lipoprotein and Coronary Atherosclerosis Study (LCAS) with fluvastatin.
Herd JA; West MS; Ballantyne C; Farmer J; Gotto AM
Am J Cardiol; 1994 May; 73(14):42D-49D. PubMed ID: 8198024
[TBL] [Abstract][Full Text] [Related]
5. Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study.
Marian AJ; Safavi F; Ferlic L; Dunn JK; Gotto AM; Ballantyne CM
J Am Coll Cardiol; 2000 Jan; 35(1):89-95. PubMed ID: 10636265
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of triple therapy (fluvastatin-bezafibrate-cholestyramine) for severe familial hypercholesterolemia.
Leitersdorf E; Muratti EN; Eliav O; Peters TK
Am J Cardiol; 1995 Jul; 76(2):84A-88A. PubMed ID: 7604807
[TBL] [Abstract][Full Text] [Related]
7. Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy.
Ballantyne CM; Herd JA; Ferlic LL; Dunn JK; Farmer JA; Jones PH; Schein JR; Gotto AM
Circulation; 1999 Feb; 99(6):736-43. PubMed ID: 9989957
[TBL] [Abstract][Full Text] [Related]
8. Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group.
Bard JM; Ose L; Hagen E; Duriez P; Pfister P; Fruchart JC; Dallongeville J
Am J Cardiol; 1995 Jul; 76(2):65A-70A. PubMed ID: 7604802
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis Study.
Sing K; Ballantyne CM; Ferlic L; Brugada R; Cushman I; Dunn JK; Herd JA; Pownall HJ; Gotto AM; Marian AJ
Atherosclerosis; 1999 Jun; 144(2):435-42. PubMed ID: 10407505
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy.
Ballantyne CM; Herd JA; Stein EA; Ferlic LL; Dunn JK; Gotto AM; Marian AJ
J Am Coll Cardiol; 2000 Nov; 36(5):1572-8. PubMed ID: 11079660
[TBL] [Abstract][Full Text] [Related]
11. A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d.
Davidson MH; Palmisano J; Wilson H; Liss C; Dicklin MR
Clin Ther; 2003 Nov; 25(11):2738-53. PubMed ID: 14693301
[TBL] [Abstract][Full Text] [Related]
12. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH
Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of fluvastatin, a totally synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. FLUENT Study Group. Fluvastatin Long-Term Extension Trial.
Zavoral JH; Haggerty BJ; Winick AG; Bergmann SD
Am J Cardiol; 1995 Jul; 76(2):37A-40A. PubMed ID: 7604795
[TBL] [Abstract][Full Text] [Related]
14. A review of current clinical findings with fluvastatin.
Garnett WR
Am J Cardiol; 1996 Sep; 78(6A):20-5. PubMed ID: 8875971
[TBL] [Abstract][Full Text] [Related]
15. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
Serruys PW; Foley DP; Jackson G; Bonnier H; Macaya C; Vrolix M; Branzi A; Shepherd J; Suryapranata H; de Feyter PJ; Melkert R; van Es GA; Pfister PJ
Eur Heart J; 1999 Jan; 20(1):58-69. PubMed ID: 10075142
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatin.
Turban S; Fuentes F; Ferlic L; Brugada R; Gotto AM; Ballantyne CM; Marian AJ
Atherosclerosis; 2001 Feb; 154(3):633-40. PubMed ID: 11257264
[TBL] [Abstract][Full Text] [Related]
17. Fluvastatin in severe hypercholesterolemia: analysis of a clinical trial database.
Peters TK
Am J Cardiol; 1995 Jul; 76(2):71A-75A. PubMed ID: 7604803
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hyperlipidemia.
Knopp RH; Frohlich J; Jokubaitis LA; Dawson K; Broyles FE; Gomez-Coronado D
Am J Med; 1994 Jun; 96(6A):69S-78S. PubMed ID: 8017470
[TBL] [Abstract][Full Text] [Related]
19. Fluvastatin in primary hypercholesterolemia: efficacy and safety in patients at high risk. An analysis of a clinical trial database.
Peters TK; Muratti EN; Mehra M
Am J Med; 1994 Jun; 96(6A):79S-83S. PubMed ID: 8017471
[TBL] [Abstract][Full Text] [Related]
20. Open-label study to assess the efficacy, safety, and tolerability of fluvastatin versus bezafibrate for hypercholesterolemia.
Fanghänel G; Espinosa J; Olivares D; Sánchez L; Morales M; Martínez L; Macías G; Valdés E; Hernández G
Am J Cardiol; 1995 Jul; 76(2):57A-61A. PubMed ID: 7604800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
